RANCHO CUCAMONGA, CA / ACCESS Newswire/ December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's ...

BROWNSBURG, IN – A medication long known for its use in substance abuse treatment is getting a second life in the world of functional medicine, offering a new approach for people suffering from ...

Treatment with low-dose naltrexone was linked to reduced pain scores and improved functional outcomes among patients with fibromyalgia. Low-dose naltrexone (LDN) significantly reduces pain and ...

A Boxed Warning explaining the risk of medication errors involving inadvertent neuraxial administration will be added to the labeling. The Food and Drug Administration (FDA) has issued an updated ...

The US Surgeon General’s Advisory in 2025 on alcohol recommended updating the warning label on alcohol-containing beverages to include cancer, counseling patients about alcohol as a cancer risk factor ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug, ...

Between Oct. 1, 2019 and Jan. 24, 2020, Peter Krag had monthly naltrexone injections supervised by Dr. Sobel’s office, the lawsuit noted. He had a positive urine test around the holidays and he was ...

Please provide your email address to receive an email when new articles are posted on . In the U.S. approximately 8% of people aged 12 years or older have alcohol use disorder (AUD), but a majority ...

Following Trump’s record-breaking series of executive orders at the start of his second term, many of his administration’s actions are being held up in federal court as judges weigh whether or not ...

Starting oral or injectable naltrexone at hospital discharge reduced heavy drinking in patients with alcohol use disorder. The hospital is an opportune setting for identifying and treating patients ...